Radiation Therapy for Pancreatic Cancer

Executive Summary of an ASTRO Clinical Practice Guideline

Manisha Palta, Devon Godfrey, Karyn A. Goodman, Sarah Hoffe, Laura A. Dawson, David Dessert, William A. Hall, Joseph M. Herman, Alok A. Khorana, Nipun Merchant, Arti Parekh, Caroline Patton, Joseph M. Pepek, Joseph K. Salama, Richard Tuli, Albert C. Koong

Research output: Contribution to journalArticle

Abstract

Purpose: This guideline systematically reviews the evidence for treatment of pancreatic cancer with radiation in the adjuvant, neoadjuvant, definitive, and palliative settings and provides recommendations on indications and technical considerations. Methods and Materials: The American Society for Radiation Oncology convened a task force to address 7 key questions focused on radiation therapy, including dose fractionation and treatment volumes, simulation and treatment planning, and prevention of radiation-associated toxicities. Recommendations were based on a systematic literature review and created using a predefined consensus-building methodology and system for grading evidence quality and recommendation strength. Results: The guideline conditionally recommends conventionally fractionated or stereotactic body radiation for neoadjuvant and definitive therapy in certain patients and conventionally fractionated regimens for adjuvant therapy. The task force suggests a range of appropriate dose-fractionation schemes and provides recommendations on target volumes and sequencing of radiation and chemotherapy. Motion management, daily image guidance, use of contrast, and treatment with modulated techniques are all recommended. The task force supported prophylactic antiemetic medication, and patients may also benefit from medications to reduce acid secretion. Conclusions: The role of radiation in the management of pancreatic cancer is evolving, with many ongoing areas of active investigation. Radiation therapy is likely to become even more important as new systemic therapies are developed and there is increased focus on controlling local disease. It is important that the nuances of available data are discussed with patients and families and that care be coordinated in a multidisciplinary fashion.

Original languageEnglish (US)
Pages (from-to)322-332
Number of pages11
JournalPractical Radiation Oncology
Volume9
Issue number5
DOIs
StatePublished - Sep 1 2019

Fingerprint

Pancreatic Neoplasms
Practice Guidelines
Radiotherapy
Radiation
Advisory Committees
Dose Fractionation
Therapeutics
Guidelines
Radiation Oncology
Neoadjuvant Therapy
Antiemetics
Consensus
Patient Care
Drug Therapy
Acids

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Palta, M., Godfrey, D., Goodman, K. A., Hoffe, S., Dawson, L. A., Dessert, D., ... Koong, A. C. (2019). Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Practical Radiation Oncology, 9(5), 322-332. https://doi.org/10.1016/j.prro.2019.06.016

Radiation Therapy for Pancreatic Cancer : Executive Summary of an ASTRO Clinical Practice Guideline. / Palta, Manisha; Godfrey, Devon; Goodman, Karyn A.; Hoffe, Sarah; Dawson, Laura A.; Dessert, David; Hall, William A.; Herman, Joseph M.; Khorana, Alok A.; Merchant, Nipun; Parekh, Arti; Patton, Caroline; Pepek, Joseph M.; Salama, Joseph K.; Tuli, Richard; Koong, Albert C.

In: Practical Radiation Oncology, Vol. 9, No. 5, 01.09.2019, p. 322-332.

Research output: Contribution to journalArticle

Palta, M, Godfrey, D, Goodman, KA, Hoffe, S, Dawson, LA, Dessert, D, Hall, WA, Herman, JM, Khorana, AA, Merchant, N, Parekh, A, Patton, C, Pepek, JM, Salama, JK, Tuli, R & Koong, AC 2019, 'Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline', Practical Radiation Oncology, vol. 9, no. 5, pp. 322-332. https://doi.org/10.1016/j.prro.2019.06.016
Palta, Manisha ; Godfrey, Devon ; Goodman, Karyn A. ; Hoffe, Sarah ; Dawson, Laura A. ; Dessert, David ; Hall, William A. ; Herman, Joseph M. ; Khorana, Alok A. ; Merchant, Nipun ; Parekh, Arti ; Patton, Caroline ; Pepek, Joseph M. ; Salama, Joseph K. ; Tuli, Richard ; Koong, Albert C. / Radiation Therapy for Pancreatic Cancer : Executive Summary of an ASTRO Clinical Practice Guideline. In: Practical Radiation Oncology. 2019 ; Vol. 9, No. 5. pp. 322-332.
@article{f706959cbd37491bbcd90ad07f14496d,
title = "Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline",
abstract = "Purpose: This guideline systematically reviews the evidence for treatment of pancreatic cancer with radiation in the adjuvant, neoadjuvant, definitive, and palliative settings and provides recommendations on indications and technical considerations. Methods and Materials: The American Society for Radiation Oncology convened a task force to address 7 key questions focused on radiation therapy, including dose fractionation and treatment volumes, simulation and treatment planning, and prevention of radiation-associated toxicities. Recommendations were based on a systematic literature review and created using a predefined consensus-building methodology and system for grading evidence quality and recommendation strength. Results: The guideline conditionally recommends conventionally fractionated or stereotactic body radiation for neoadjuvant and definitive therapy in certain patients and conventionally fractionated regimens for adjuvant therapy. The task force suggests a range of appropriate dose-fractionation schemes and provides recommendations on target volumes and sequencing of radiation and chemotherapy. Motion management, daily image guidance, use of contrast, and treatment with modulated techniques are all recommended. The task force supported prophylactic antiemetic medication, and patients may also benefit from medications to reduce acid secretion. Conclusions: The role of radiation in the management of pancreatic cancer is evolving, with many ongoing areas of active investigation. Radiation therapy is likely to become even more important as new systemic therapies are developed and there is increased focus on controlling local disease. It is important that the nuances of available data are discussed with patients and families and that care be coordinated in a multidisciplinary fashion.",
author = "Manisha Palta and Devon Godfrey and Goodman, {Karyn A.} and Sarah Hoffe and Dawson, {Laura A.} and David Dessert and Hall, {William A.} and Herman, {Joseph M.} and Khorana, {Alok A.} and Nipun Merchant and Arti Parekh and Caroline Patton and Pepek, {Joseph M.} and Salama, {Joseph K.} and Richard Tuli and Koong, {Albert C.}",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.prro.2019.06.016",
language = "English (US)",
volume = "9",
pages = "322--332",
journal = "Practical Radiation Oncology",
issn = "1879-8500",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Radiation Therapy for Pancreatic Cancer

T2 - Executive Summary of an ASTRO Clinical Practice Guideline

AU - Palta, Manisha

AU - Godfrey, Devon

AU - Goodman, Karyn A.

AU - Hoffe, Sarah

AU - Dawson, Laura A.

AU - Dessert, David

AU - Hall, William A.

AU - Herman, Joseph M.

AU - Khorana, Alok A.

AU - Merchant, Nipun

AU - Parekh, Arti

AU - Patton, Caroline

AU - Pepek, Joseph M.

AU - Salama, Joseph K.

AU - Tuli, Richard

AU - Koong, Albert C.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Purpose: This guideline systematically reviews the evidence for treatment of pancreatic cancer with radiation in the adjuvant, neoadjuvant, definitive, and palliative settings and provides recommendations on indications and technical considerations. Methods and Materials: The American Society for Radiation Oncology convened a task force to address 7 key questions focused on radiation therapy, including dose fractionation and treatment volumes, simulation and treatment planning, and prevention of radiation-associated toxicities. Recommendations were based on a systematic literature review and created using a predefined consensus-building methodology and system for grading evidence quality and recommendation strength. Results: The guideline conditionally recommends conventionally fractionated or stereotactic body radiation for neoadjuvant and definitive therapy in certain patients and conventionally fractionated regimens for adjuvant therapy. The task force suggests a range of appropriate dose-fractionation schemes and provides recommendations on target volumes and sequencing of radiation and chemotherapy. Motion management, daily image guidance, use of contrast, and treatment with modulated techniques are all recommended. The task force supported prophylactic antiemetic medication, and patients may also benefit from medications to reduce acid secretion. Conclusions: The role of radiation in the management of pancreatic cancer is evolving, with many ongoing areas of active investigation. Radiation therapy is likely to become even more important as new systemic therapies are developed and there is increased focus on controlling local disease. It is important that the nuances of available data are discussed with patients and families and that care be coordinated in a multidisciplinary fashion.

AB - Purpose: This guideline systematically reviews the evidence for treatment of pancreatic cancer with radiation in the adjuvant, neoadjuvant, definitive, and palliative settings and provides recommendations on indications and technical considerations. Methods and Materials: The American Society for Radiation Oncology convened a task force to address 7 key questions focused on radiation therapy, including dose fractionation and treatment volumes, simulation and treatment planning, and prevention of radiation-associated toxicities. Recommendations were based on a systematic literature review and created using a predefined consensus-building methodology and system for grading evidence quality and recommendation strength. Results: The guideline conditionally recommends conventionally fractionated or stereotactic body radiation for neoadjuvant and definitive therapy in certain patients and conventionally fractionated regimens for adjuvant therapy. The task force suggests a range of appropriate dose-fractionation schemes and provides recommendations on target volumes and sequencing of radiation and chemotherapy. Motion management, daily image guidance, use of contrast, and treatment with modulated techniques are all recommended. The task force supported prophylactic antiemetic medication, and patients may also benefit from medications to reduce acid secretion. Conclusions: The role of radiation in the management of pancreatic cancer is evolving, with many ongoing areas of active investigation. Radiation therapy is likely to become even more important as new systemic therapies are developed and there is increased focus on controlling local disease. It is important that the nuances of available data are discussed with patients and families and that care be coordinated in a multidisciplinary fashion.

UR - http://www.scopus.com/inward/record.url?scp=85070874820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070874820&partnerID=8YFLogxK

U2 - 10.1016/j.prro.2019.06.016

DO - 10.1016/j.prro.2019.06.016

M3 - Article

VL - 9

SP - 322

EP - 332

JO - Practical Radiation Oncology

JF - Practical Radiation Oncology

SN - 1879-8500

IS - 5

ER -